查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950311

環肽化妝品市場按產品類型、最終用戶、價格範圍、分銷管道和應用分類，全球預測（2026-2032年）

Cyclic Peptide Cosmetics Market by Product Type, End User, Price Range, Distribution Channel, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，循環胜肽化妝品市場價值將達到 3.5542 億美元，到 2026 年將成長至 3.9434 億美元，到 2032 年將達到 7.8037 億美元，複合年成長率為 11.89%。

關鍵市場統計數據
基準年 2025 3.5542億美元
預計年份：2026年 3.9434億美元
預測年份 2032 7.8037億美元
複合年成長率 (%) 11.89%

本書全面介紹了環肽化妝品市場，概述了科學進展、消費者期望、監管現狀以及市場准入的策略路徑。

環肽化妝品市場的發展是由分子創新與消費者對科學驗證、高效個人保健產品的需求共同塑造的。胜肽合成和穩定技術的進步日益受到關注，成為活性成分，與線性胜肽相比，環肽具有許多優勢，包括更高的功效、更強的靶向特異性和更好的皮膚滲透性。這些技術進步與消費者對能夠帶來可衡量益處的產品的偏好相契合，尤其是在抗衰老和修復護膚，同時這些產品也符合簡化的護膚流程和符合道德規範的採購政策。因此，配方師、原料供應商和品牌負責人正在重新評估其產品開發藍圖，以融入能夠平衡功效、感官體驗和穩定性要求的胜肽化學技術。

深入檢驗正在重塑產品設計、科學檢驗、供應鏈策略和消費者互動模式的催化變革

目前，化妝品產業正經歷一系列變革，這些變革正在重新定義產品提案和商業策略。合成、胜肽環化和遞送系統的進步，在提高產品在典型化妝品儲存和使用條件下穩定性的同時，也減少了臨床試驗的需求。同時，該行業正從單一成分療法轉向綜合護理系統，其中循環肽在複雜的配方中發揮作用，以應對複雜的衰老、修復和色素沉著問題。這種整合促進了生物化學家、配方化學家和感官科學家之間的跨學科合作，從而在不犧牲質地、香味或貨架穩定性的前提下，提供更佳的性能。

重點分析2025年美國關稅調整對原物料採購、製造在地化和商業性定價策略的影響

美國近期推出的關稅政策為化妝品產業的原物料採購、生產經濟和定價策略帶來了新的複雜性。 2025年宣布的關稅調整尤其會影響特種胜肽中間體和精密試劑的原料流動，這些原料通常透過跨境供應鏈採購或生產。其累積影響不僅限於直接成本增加，還會限制供應商的柔軟性，促使某些工序在地化，並加速供應商網路的多元化。品牌商和配方師可以透過重新談判供應商合約、選擇替代化學方法或將高附加價值活動轉移到更靠近終端市場的地方來降低關稅風險。

將產品類型、分銷通路趨勢、應用需求、使用者群體特徵和價格策略與商業性成果連結起來的詳細細分分析

細分市場分析揭示了不同產品類型、分銷管道、應用領域、最終用戶和價格點所帶來的不同的市場採納路徑和商業性表現。產品線涵蓋乳霜、凝膠、乳液、面膜和精華液，每種產品都需要專門的配方策略來最佳化胜肽的穩定性、感官特性和劑量。長期穩定性和乳化劑的相容性是乳霜和乳液面臨的挑戰。快速滲透和避免使用不穩定的添加劑是凝膠和精華液的首要任務。面膜則憑藉其高濃度、短時接觸的特性，能夠達到快速起效。分銷模式正朝著線上線下融合的方向發展，線上和線下管道在不同的營運規則下並存。線下通路包括大賣場、超市、藥局和專賣店，以及注重專家推薦和體驗式探索的專賣店。線上通路則透過品牌官網和履約平台進行銷售，後者也包括第三方零售商以擴大覆蓋範圍，但這需要差異化的產品陳列和物流配送方式。

策略區域分析：重點闡述美洲、歐洲、中東和非洲以及亞太地區將如何分別影響合規性、籌資策略和消費者共鳴。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的產品設計、監管策略和市場推廣策略產生了顯著影響。在美洲，消費者越來越親和性經臨床檢驗的活性成分和高階產品特性，促使品牌優先考慮可衡量的效果和與皮膚科醫師的合作。同時，物流網路強調快速上市和及時補貨。該地區的監管工作主要圍繞著清晰的標籤、有依據的聲明以及符合聯邦要求的安全文件。歐洲、中東和非洲的情況則更為複雜，嚴格的化妝品安全法規與消費者偏好的區域差異並存，這既為差異化配方的開發帶來了挑戰，也帶來了機會。該地區的成功品牌將嚴格遵守法規與契合當地文化的行銷策略相結合，以滿足當地膚質和氣候條件的需求。

深入剖析原料開發商、專業製造商和消費品牌如何透過合作、臨床證據和供應鏈彈性來攜手共進，從而形成競爭格局。

環肽化妝品領域的競爭格局以原料開發商、契約製造和消費品牌之間的合作為特徵，並由專業的服務供應商提供臨床檢驗和法規事務支援。原料開發商專注於為新型環狀序列和遞送平台獲取智慧財產權，以增強皮膚滲透性和穩定性；契約製造生產商則憑藉其大規模胜肽加工能力和無塵室技術脫穎而出。消費品牌涵蓋了從涉足胜肽技術領域的成熟品牌到利用精準的科學故事和D2C管道加速試驗的敏捷新興品牌。合作關係和授權協議正變得越來越普遍，成為在不損害品牌價值的前提下整合配方技術和分銷能力的一種方式。

為領導者提供切實可行的、優先考慮的建議，內容涵蓋確保胜肽穩定性、實現採購多元化、證明功效以及調整通路策略以實現永續成長。

行業領導者應採取多管齊下的行動計劃，將科學潛力轉化為永續的商業性回報。首先，優先考慮能夠最佳化環肽在各種目標產品形式中穩定性並保持理想感官特性的配方策略。投資最佳化遞送系統和輔料，以確保產品效能，同時不影響消費者體驗。其次，建立優先供應商選擇計劃和關鍵中間體的雙重採購安排，以降低關稅和地緣政治風險，並在必要時實現向區域生產的戰術性轉移。第三，透過有針對性的臨床終點和生物標記追蹤，加快證據生成，並將結果以面向消費者的故事形式呈現，將分子作用與實際結果聯繫起來。

我們以透明的方式解釋我們的混合調查方法，結合專家訪談、文獻綜述、監管審查和情境分析，以確保提供可操作的證據。

本分析所依據的研究採用多層次的調查方法，旨在全面了解環肽化妝品的科學、商業性和監管層面。主要資訊來源包括對配方化學家、原料供應商、契約製造生產商、監管專家和行銷負責人進行的結構化訪談，以獲取有關技術挑戰、供應鏈脆弱性和消費者定位策略的第一手資訊。次要研究則利用同儕審查文獻、專利狀態、監管指導文件以及相關產業相關人員的公開文件，來檢驗作用機制聲明並展現創新軌跡。此外，還審查了貿易和海關文件，以了解可能影響關稅分類和原料分銷的貿易手段。

這是一份簡潔的概述，它將科學可能性與商業性需求聯繫起來，並強調了成功所需的合作、示範和營運規範。

循環胜肽化妝品領域融合了紮實的科學基礎和清晰的消費者需求，為能夠全面應對技術、法規和商業性複雜性的品牌提供了差異化的機會。成功之路並非僅僅依靠個人創新，更需要系統性的思維，將卓越的配方、供應鏈開發、臨床驗證和分銷管道整合起來。儘管關稅壓力和區域監管差異會帶來營運上的限制，但也促使企業採取更注重供應來源多元化、在地化生產和更智慧的產品線選擇的策略。積極應對這些因素的企業將增強供應商的議價能力，透過透明的證據提升消費者信任度，並在競爭激烈的通路中佔據高階地位。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：環肽化妝品市場（依產品類型分類）

  • 奶油
  • 凝膠
  • 洗劑
  • 面具
  • 美容精華液

第9章 環肽化妝品市場（按最終用戶分類）

  • 女士
  • 男性
  • 男女通用的

第10章：環肽化妝品市場（以價格範圍分類）

  • 奢華
    • 奢華
    • 極致奢華
  • 大眾市場
  • 中檔
  • 優質的

第11章 環肽化妝品市場（依通路分類）

  • 離線
    • 大賣場和超級市場
    • 藥房和藥品商店
    • 專賣店
  • 線上
    • 品牌官方網站
    • 電子商務平台

第12章 環肽化妝品市場（依應用領域分類）

  • 抗衰老
  • 護髮
    • 脫髮症治療
    • 強韌秀髮
    • 頭皮健康
  • 皮膚修復/保護
  • 美白和改善膚色

第13章：環肽化妝品市場區域分析

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 環肽化妝品市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國環肽化妝品市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國環胜肽化妝品市場

第17章 中國環肽化妝品市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Active Peptide Company
  • Ashland Global Holdings, Inc.
  • Bachem Holding AG
  • BASF SE
  • Croda International Plc
  • DSM-Firmenich
  • Evonik Industries AG
  • Givaudan SA
  • Lipotec
  • Lonza Group AG
  • Merck KGaA
  • PeptiDream Inc.
  • PolyPeptide Group A/S
  • Royal DSM NV
  • Spec-Chem Industry Inc.
  • Symrise AG
  • The Lubrizol Corporation
  • WuXi AppTec Co., Ltd.
Product Code: MRR-4F7A6D4FD7E2

The Cyclic Peptide Cosmetics Market was valued at USD 355.42 million in 2025 and is projected to grow to USD 394.34 million in 2026, with a CAGR of 11.89%, reaching USD 780.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 355.42 million
Estimated Year [2026] USD 394.34 million
Forecast Year [2032] USD 780.37 million
CAGR (%) 11.89%

A decisive introduction to cyclic peptide cosmetics that outlines scientific advances, consumer expectations, regulatory realities and strategic pathways for market entry

The landscape of cyclic peptide cosmetics is defined by an intersection of molecular innovation and consumer demand for high-performance, science-backed personal care. Advances in peptide synthesis and stabilization have made cyclic peptides increasingly attractive as active ingredients due to their enhanced potency, target specificity, and improved skin penetration compared with linear analogues. These technical advances are converging with consumer preferences for products that deliver measurable benefits-particularly in anti-aging and restorative skin care-while also fitting into streamlined routines and ethical sourcing narratives. As a result, formulators, ingredient suppliers, and brand strategists are reevaluating product development roadmaps to incorporate peptide chemistries that balance efficacy with sensory and stability requirements.

Transitioning from lab to shelf requires careful coordination across R&D, regulatory, and commercial functions. Regulatory clarity around novel bioactive claims and safety testing protocols is maturing, prompting companies to adopt more rigorous clinical endpoints and in vitro models during development. Meanwhile, consumer education and transparent communication have become keystones of adoption, because trust in bioactive cosmetic ingredients correlates with willingness to pay and trial behavior. In this context, stakeholders that integrate robust science with compelling storytelling, reliable manufacturing, and channel-specific go-to-market plans position themselves to capture premium segments while reducing commercial friction.

An in depth examination of the catalytic shifts reshaping product design, scientific validation, supply chain strategies and consumer engagement models

The industry is undergoing a suite of transformative shifts that are redefining product propositions and commercial tactics. Technological advancements in synthesis, peptide cyclization techniques, and delivery systems are enabling smaller clinical footprints while improving stability under typical cosmetic storage and use conditions. Concurrently, the industry is seeing a move away from single-ingredient hero narratives toward integrated regimens where cyclic peptides function within multi-modal formulations to address complex aging, repair, and pigmentation concerns. This integration is prompting cross-functional collaboration between biochemists, formulation chemists, and sensory scientists to ensure that performance gains do not come at the expense of texture, fragrance, or shelf stability.

On the commercial side, consumers increasingly demand verifiable efficacy and clear provenance. This has accelerated investment in targeted clinical studies, biomarker validation, and third-party dermatological endorsements. Retail dynamics are also shifting; premiumization trends and the growth of experience-driven retail are increasing the importance of in-store education and digital storytelling. Supply chains are adapting to these pressures through strategic sourcing partnerships and modular manufacturing arrangements that preserve ingredient traceability while offering scale. Finally, sustainability and circularity considerations are moving from marketing touchpoints to product development parameters, influencing packaging choices and ingredient sourcing decisions in ways that will shape competitive differentiation over the coming years.

A focused exploration of how united states tariff adjustments in twenty twenty five are reshaping ingredient sourcing, manufacturing localization and commercial pricing strategies

Recent tariff policies in the United States have introduced a new layer of complexity for ingredient procurement, manufacturing economics, and pricing strategies across the cosmetics ecosystem. Tariff adjustments announced for two thousand twenty five are affecting raw material flows, particularly for specialized peptide intermediates and precision reagents that are often sourced or manufactured through cross-border supply chains. The cumulative impact is not limited to direct cost increases; it also compresses supplier flexibility, incentivizes localization of certain production steps, and accelerates diversification of supplier networks. Brands and formulators may respond by renegotiating supplier contracts, qualifying alternative chemistries, or shifting higher value-added activities closer to final markets to mitigate tariff exposure.

In parallel, the administrative friction associated with customs classification and compliance has raised the importance of tariff engineering and proactive regulatory engagement. Companies are investing in origin and content documentation, harmonized system code reviews, and strategic allocation of intellectual property to minimize duty burdens while respecting trade law. Over time, these shifts can influence product assortment decisions, with some brands preferring formulations that rely on domestically available inputs or regional contract manufacturing. As a result, pricing architectures and promotional mechanics may evolve to reflect the increased cost of entry for peptide-forward formulations, prompting a reappraisal of margin expectations and channel investments.

A granular segmentation perspective mapping product formats, channel dynamics, application needs, user demographics and price tier strategies to commercial outcomes

Segmentation analysis reveals differentiated pathways to adoption and commercial performance across product types, distribution channels, applications, end users, and price positions. Product offerings span creams, gels, lotions, masks and serums, each requiring tailored formulation strategies to optimize peptide stability, sensory profile and dosing. In creams and lotions the challenge is long-term stability and emulsion compatibility; gels and serums prioritize rapid delivery and avoidance of destabilizing excipients; masks present opportunities for high-dose, short-duration exposure profiles that can accelerate perceptible benefits. Distribution evolves along a bifurcated retail model where offline and online channels coexist with distinct operating rules. Offline distribution encompasses hypermarkets and supermarkets, pharmacies and drug stores, and specialty stores that emphasize professional endorsement and experiential discovery. Online distribution operates through brand websites and e-commerce platforms, the latter of which includes third-party retailers that amplify reach but require differentiated merchandising and fulfillment approaches.

Applications concentrate on anti-aging, hair care, skin repair and protection, and whitening and brightening, with hair care further segmented into hair loss treatment, hair strengthening and scalp health, each demanding unique delivery strategies and claims substantiation. End users are categorized as female, male and unisex, which affects tone, packaging, and product architecture. Price positioning ranges from luxury through mid-range and premium to mass market, with luxury splitting into high-luxury and ultra-luxury tiers and mass market incorporating value propositions. Each segmentation axis informs R&D priorities, marketing narratives and channel allocation, and the most successful strategies align formulation choices with the expectations of targeted distribution partners and consumer cohorts.

A strategic regional analysis highlighting how the americas, europe middle east and africa, and asia pacific each influence compliance, sourcing strategies and consumer resonance

Regional dynamics are exerting a material influence on product design, regulatory strategy, and go-to-market execution across the Americas, Europe Middle East and Africa, and Asia Pacific. In the Americas, consumer affinity for clinically validated actives and premium claims is driving brands to prioritize measurable outcomes and dermatologist partnerships, while logistics networks emphasize speed to market and rapid inventory replenishment. Regulatory engagement in this region centers on clear labeling, substantiated claims, and safety dossiers that align with federal authority expectations. Moving to Europe Middle East and Africa, the landscape is markedly diverse; stringent cosmetic safety frameworks coexist with regional variations in consumer preferences, creating both barriers and opportunities for differentiated formulations. Brands that navigate this region successfully combine rigorous compliance with culturally resonant marketing that addresses local skin typologies and climate considerations.

Asia Pacific presents the most heterogeneous demand signals, with pockets of early adoption driven by beauty-tech integration, social commerce, and a high premium on innovation pedigree. In several markets within the region, consumers actively seek next-generation actives and are highly responsive to influencer and micro-influencer validation. Supply chain and manufacturing hubs in Asia Pacific also play a central role in global peptide ingredient workflows, which makes regional sourcing and contract manufacturing options strategically important for global brand portfolios. Across all regions, companies must reconcile global branding consistency with local regulatory nuances and distribution realities to realize sustained commercial traction.

A sharp look at competitive approaches where ingredient innovators, specialist manufacturers and consumer brands converge through partnerships, clinical evidence and supply resilience

Competitive dynamics in the cyclic peptide cosmetics space are characterized by collaboration between ingredient innovators, contract manufacturers, and consumer brands, supported by specialized service providers for clinical validation and regulatory counsel. Ingredient developers are focusing on securing intellectual property around novel cyclic sequences and delivery platforms that enhance dermal penetration and stability, while contract manufacturers are differentiating through scalable peptide handling capabilities and cleanroom expertise. Consumer brands range from established heritage names extending into peptide technologies to agile challenger brands that leverage targeted science narratives and direct-to-consumer channels to accelerate trial. Partnerships and licensing agreements are increasingly common as a way to pair formulation know-how with distribution muscle without diluting brand equity.

Strategic players are investing in proprietary assays and dermatological endpoints to substantiate claims, creating a higher barrier to entry for competitors who lack clinical infrastructure. At the same time, supply chain resilience is becoming a differentiator, with firms that maintain multi-source strategies for critical intermediates and that invest in production geography flexibility gaining steadier access to input materials. Collaborations with academic labs and biotech companies provide an added edge in accelerating preclinical validation and translating mechanistic insights into commercially relevant benefits. Overall, success in this segment hinges on the ability to blend differentiated scientific evidence with dependable manufacturing and clear consumer communication.

Practical and prioritized recommendations for leaders to secure peptide stability, diversify sourcing, prove efficacy and align channel strategies for sustainable growth

Industry leaders should adopt a multifaceted action plan to translate scientific promise into durable commercial returns. First, prioritize formulation strategies that optimize cyclic peptide stability across intended product formats while preserving desirable sensory attributes; invest in delivery systems and excipient optimization to ensure performance without compromising consumer experience. Second, establish prioritized supplier qualification programs and dual-sourcing arrangements for critical intermediates to mitigate tariff and geopolitical risks while enabling tactical shifts to regional manufacturing when necessary. Third, accelerate evidence generation through targeted clinical endpoints and biomarker tracking, and frame results in consumer-friendly narratives that link molecular action to visible outcomes.

Next, align channel strategies with product archetypes: reserve high-touch experiential and professional channels for premium, clinic-oriented offerings while using brand websites and third-party marketplaces for broad accessibility and data capture. Leverage price tier segmentation by offering tiered regimens that encourage migration from trial sizes to full routines. Invest in regulatory and customs expertise to manage classification and tariff engineering proactively, and develop packaging and sustainability narratives that resonate across key regions. Finally, pursue strategic partnerships with specialized biotech suppliers and clinical institutions to accelerate innovation cycles and protect intellectual property through well-structured licensing or co-development agreements. These coordinated actions will strengthen product integrity, reduce commercial risk, and support scalable growth.

A transparent description of the mixed methods research approach combining expert interviews, literature synthesis, regulatory review and scenario analysis to ensure actionable evidence

The research underpinning this analysis combined a layered methodology designed to capture scientific, commercial, and regulatory dimensions of cyclic peptide cosmetics. Primary inputs included structured interviews with formulation chemists, ingredient suppliers, contract manufacturers, regulatory specialists and marketing leaders to gather first-hand insights into technical hurdles, supply chain sensitivities, and consumer positioning strategies. Secondary research drew on peer-reviewed literature, patent landscapes, regulatory guidance documents, and public filings from relevant industry participants to validate mechanistic claims and to map innovation trajectories. Trade and customs documentation were examined to understand tariff classifications and potential trade engineering levers that influence ingredient flows.

Analytical techniques included cross-validation of qualitative interview themes with secondary evidence, scenario mapping to evaluate the practical implications of tariff changes, and segmentation overlay to align product archetypes with channel, application and price position. Where appropriate, clinical study designs and typical dermatological endpoints were reviewed to assess the strength of evidence supporting common claims. Data integrity was maintained through source triangulation, and all recommendations prioritize operational feasibility and regulatory compliance. This mixed-methods approach ensures the analysis remains grounded in real-world constraints while highlighting actionable strategic options.

A concise closing synthesis that ties scientific potential to commercial imperatives and underscores collaboration, evidence and operational discipline for success

Cyclic peptide cosmetics represent a convergence of credible science and palpable consumer demand, presenting differentiated opportunities for brands that can manage technical, regulatory, and commercial complexities in concert. The pathway to success requires more than isolated innovation; it demands systems thinking that aligns formulation excellence, supply chain architecture, clinical substantiation, and channel execution. Tariff pressures and regional regulatory differences add operational constraints but also catalyze strategies that emphasize supply diversification, localized manufacturing, and smarter product assortment choices. Companies that proactively address these levers will strengthen their negotiating position with suppliers, accelerate consumer trust through transparent evidence, and secure premium positioning in competitive channels.

Looking ahead, the most resilient players will be those that can operationalize scientific advantages into repeatable, consumer-facing formats that balance efficacy with sensory and ethical considerations. Collaboration across the value chain-between ingredient creators, contract manufacturers, clinicians, and retail partners-will continue to accelerate product maturation and consumer adoption. Ultimately, strategic discipline in product design, evidence generation, and market execution will determine which organizations capitalize on the promise of cyclic peptides versus those that experience incremental gains without sustained commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cyclic Peptide Cosmetics Market, by Product Type

  • 8.1. Creams
  • 8.2. Gels
  • 8.3. Lotions
  • 8.4. Masks
  • 8.5. Serums

9. Cyclic Peptide Cosmetics Market, by End User

  • 9.1. Female
  • 9.2. Male
  • 9.3. Unisex

10. Cyclic Peptide Cosmetics Market, by Price Range

  • 10.1. Luxury
    • 10.1.1. High-Luxury
    • 10.1.2. Ultra-Luxury
  • 10.2. Mass Market
  • 10.3. Mid-Range
  • 10.4. Premium

11. Cyclic Peptide Cosmetics Market, by Distribution Channel

  • 11.1. Offline
    • 11.1.1. Hypermarkets & Supermarkets
    • 11.1.2. Pharmacies & Drug Stores
    • 11.1.3. Specialty Stores
  • 11.2. Online
    • 11.2.1. Brand Website
    • 11.2.2. E-Commerce Platform

12. Cyclic Peptide Cosmetics Market, by Application

  • 12.1. Anti-Aging
  • 12.2. Hair Care
    • 12.2.1. Hair Loss Treatment
    • 12.2.2. Hair Strengthening
    • 12.2.3. Scalp Health
  • 12.3. Skin Repair & Protection
  • 12.4. Whitening & Brightening

13. Cyclic Peptide Cosmetics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cyclic Peptide Cosmetics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cyclic Peptide Cosmetics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Cyclic Peptide Cosmetics Market

17. China Cyclic Peptide Cosmetics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Active Peptide Company
  • 18.6. Ashland Global Holdings, Inc.
  • 18.7. Bachem Holding AG
  • 18.8. BASF SE
  • 18.9. Croda International Plc
  • 18.10. DSM-Firmenich
  • 18.11. Evonik Industries AG
  • 18.12. Givaudan SA
  • 18.13. Lipotec
  • 18.14. Lonza Group AG
  • 18.15. Merck KGaA
  • 18.16. PeptiDream Inc.
  • 18.17. PolyPeptide Group A/S
  • 18.18. Royal DSM N.V.
  • 18.19. Spec-Chem Industry Inc.
  • 18.20. Symrise AG
  • 18.21. The Lubrizol Corporation
  • 18.22. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CYCLIC PEPTIDE COSMETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CYCLIC PEPTIDE COSMETICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY CREAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LOTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LOTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MASKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MASKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MASKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SERUMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SERUMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SERUMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY UNISEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY UNISEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY UNISEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HIGH-LUXURY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HIGH-LUXURY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HIGH-LUXURY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ULTRA-LUXURY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ULTRA-LUXURY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ULTRA-LUXURY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MASS MARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MASS MARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MASS MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MID-RANGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MID-RANGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY MID-RANGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PREMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PREMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PREMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY BRAND WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY BRAND WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY BRAND WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY E-COMMERCE PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY E-COMMERCE PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY E-COMMERCE PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ANTI-AGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ANTI-AGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ANTI-AGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR LOSS TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR LOSS TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR LOSS TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR STRENGTHENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR STRENGTHENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR STRENGTHENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SCALP HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SCALP HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SCALP HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SKIN REPAIR & PROTECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SKIN REPAIR & PROTECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SKIN REPAIR & PROTECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY WHITENING & BRIGHTENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY WHITENING & BRIGHTENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY WHITENING & BRIGHTENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. GCC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. GCC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. GCC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 195. GCC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. GCC CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. G7 CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. G7 CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 225. G7 CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. G7 CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 227. NATO CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. NATO CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 232. NATO CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. NATO CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 235. NATO CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. NATO CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES CYCLIC PEPTIDE COSMETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA CYCLIC PEPTIDE COSMETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY LUXURY, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA CYCLIC PEPTIDE COSMETICS MARKET SIZE, BY HAIR CARE, 2018-2032 (USD MILLION)